{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:37:38Z","timestamp":1759091858460},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metast Rev"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00689635","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T17:47:33Z","timestamp":1101664053000},"page":"175-189","source":"Crossref","is-referenced-by-count":23,"title":["Signaling and drug sensitivity"],"prefix":"10.1007","volume":"13","author":[{"given":"Randolph D.","family":"Christen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Isonishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti P.","family":"Jekunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen K.","family":"Hom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Relef","family":"Kr\ufffdning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P.","family":"Gately","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz B.","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Los","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(91)90639-G","volume":"64","author":"LC Cantley","year":"1991","unstructured":"Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64: 281?301, 1991","journal-title":"Cell"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1126\/science.1659742","volume":"254","author":"SA Aaronson","year":"1991","unstructured":"Aaronson SA: Growth factors and cancer. Science 254: 1146?1153, 1991","journal-title":"Science"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1073\/pnas.76.11.5669","volume":"76","author":"RJ Kaufman","year":"1979","unstructured":"Kaufman RJ, Brown PC, Schimke RT: Amplified dihydrofolate reductase genes in unstably methotreaxate-resistant cells are associated with double minute chromosomes. Proc Natl Acad Sci USA 76: 5669?5673, 1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1016\/S0021-9258(18)37730-5","volume":"263","author":"MM Gottesman","year":"1988","unstructured":"Gottesman MM, Pastan I: The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163?12166, 1988","journal-title":"J Biol Chem"},{"key":"CR5","first-page":"35","volume":"2","author":"PA Andrews","year":"1990","unstructured":"Andrews PA, Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35?43, 1990","journal-title":"Cancer Cells"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00263887","volume":"15","author":"K Inoue","year":"1985","unstructured":"Inoue K, Mukaiyama T, Mitsui I, Ogawa M:In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. Cancer Chemother Pharmacol 15: 208?213, 1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/bjc.1984.178","volume":"50","author":"AP Simmonds","year":"1984","unstructured":"Simmonds AP, McDonald EC: Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay. Br J Cancer 50: 317?326, 1984","journal-title":"Br J Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/bjc.1987.285","volume":"56","author":"AP Wilson","year":"1987","unstructured":"Wilson AP, Ford CHJ, Newman CE, Howell A: Cis-platinum and ovarian carcinoma.In vitro chemosensitivity of cultured tumor cells from patients receiving high-dose cisplatinum. Br J Cancer 56: 763?773, 1987","journal-title":"Br J Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ijc.2910390607","volume":"39","author":"CR Wolf","year":"1987","unstructured":"Wolf CR, Hayward IP, Lawrie SS, Buckton K, McIntyre MA, Adams DJ, Lewis AD, Scott AR, Smyth JF: Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer 39: 695?702, 1987","journal-title":"Int J Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3727\/095535490820874641","volume":"2","author":"PA Andrews","year":"1990","unstructured":"Andrews PA, Jones JA, Varki NM, Howell SB: Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in anin vivo model of human ovarian carcinoma. Cancer Commun 2: 93?100, 1990","journal-title":"Cancer Commun"},{"key":"CR11","first-page":"6549","volume":"47","author":"WR Waud","year":"1987","unstructured":"Waud WR: Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells. Cancer Res 47: 6549?6555, 1987","journal-title":"Cancer Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0002-9378(72)90109-3","volume":"114","author":"PJ DiSaia","year":"1972","unstructured":"DiSaia PJ, Sinkovics JG, Rutlege FN, Smith JP: Cell-mediated immunity to human malignant cells. Am J Obstet Gynecol 114: 979?989, 1972","journal-title":"Am J Obstet Gynecol"},{"key":"CR13","first-page":"6250","volume":"45","author":"PA Andrews","year":"1985","unstructured":"Andrews PA, Murphy MP, Howell SB: Differential potentiation of alkylating and platinating agent toxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45: 6250?6253, 1985","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","volume":"61","author":"A Ullrich","year":"1990","unstructured":"Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203?212, 1990","journal-title":"Cell"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.bi.48.070179.001205","volume":"48","author":"G Carpenter","year":"1979","unstructured":"Carpenter G: Epidermal growth factor. Ann Rev Biochem 48: 193?216, 1979","journal-title":"Ann Rev Biochem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4827(86)90449-0","volume":"164","author":"G Carpenter","year":"1986","unstructured":"Carpenter G, Zendegui JG: Epidermal growth factor, its receptor, and related proteins. Exp Cell Res 164: 1?10, 1986","journal-title":"Exp Cell Res"},{"key":"CR17","first-page":"430","volume":"32","author":"RD Christen","year":"1991","unstructured":"Christen RD, Hom DK, Eastman A, Howell SB: Epidermal growth factor regulates the ability of human ovarian carcinoma cells to repair DNA damage. Proc Am Assoc Cancer Res 32: 430, 1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1172\/JCI114885","volume":"86","author":"RD Christen","year":"1990","unstructured":"Christen RD, Hom DK, Porter DC, Andrews PA, MacLeod CL, Howell SB: Epidermal growth factor regulates thein vitro sensitivity of human ovarian carcinoma cells to cisplatin. J Clin Invest 86: 1632?1640, 1990","journal-title":"J Clin Invest"},{"key":"CR19","first-page":"4449","volume":"39","author":"LK Woods","year":"1979","unstructured":"Woods LK, Morgan RT, Quinn LA, Moore GE, Semple TU, Stedman KE: Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res 39: 4449?4459, 1979","journal-title":"Cancer Res"},{"key":"CR20","first-page":"321","volume":"35","author":"R Kroning","year":"1994","unstructured":"Kroning R, Christen RD, Los G, Jones JA, Howell SB: Recombinant human EGF enhances the sensitivity of a broad spectrum of human cancer cells to cisplatin. (Abstract). Proc Am Assoc Cancer Res 35: 321, 1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/978-1-4613-1717-3_20","volume-title":"Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy","author":"A Eastman","year":"1988","unstructured":"Eastman A, Schulte N, Sheibani N, Sorenson CM: Mechanisms of resistance to platinum drugs. In: Niccolini N (ed) Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Martinus Nijhoff Publishing, Boston, MA, 1988, pp 178?192"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI115080","volume":"87","author":"RJ Parker","year":"1991","unstructured":"Parker RJ, Eastman A, Bostick-Bruton F, Reed E: Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87: 772?777, 1991","journal-title":"J Clin Invest"},{"key":"CR23","first-page":"1301","volume":"9","author":"KJ Scanlon","year":"1989","unstructured":"Scanlon KJ, Kashani-Sabet M, Miyachi H, Sowers LC, Rossi J: Molecular basis of cisplatin resistance in human carcinomas, model systems and patients. Anticancer Res 9: 1301?1312, 1989","journal-title":"Anticancer Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1042\/bj1740883","volume":"174","author":"I Bremner","year":"1978","unstructured":"Bremner I, Hoekstra WG, Davies NT, Young BW: Effect of zinc status of rats on the synthesis and degradation of copper-induced metallothioneins. Biochem J 174: 883?892, 1978","journal-title":"Biochem J"},{"key":"CR25","first-page":"130","volume":"191","author":"ML Chen","year":"1989","unstructured":"Chen ML, Failla ML: Degradation of zinc-metallothionein in monolayer cultures of rat hepatocytes. PSEBM 191: 130?138, 1989","journal-title":"PSEBM"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1021\/bi00285a031","volume":"22","author":"A Eastman","year":"1983","unstructured":"Eastman A: Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum. Biochemistry 22: 3927?3933, 1983","journal-title":"Biochemistry"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1751-1097.1989.tb05578.x","volume":"49","author":"DL Mitchell","year":"1989","unstructured":"Mitchell DL, Nairn RS: The biology of the (6-4) photoproduct. Photochem Photobiol 49: 805?819, 1989","journal-title":"Photochem Photobiol"},{"key":"CR28","first-page":"3019","volume":"48","author":"P Bedford","year":"1988","unstructured":"Bedford P, Fichtinger-Schepman AMJ, Sellard SA, Walker MC, Masters JRW, Hill BT: Differential repair of platinum-DNA adducts in human bladder and testicular continuous cell lines. Cancer Res 48: 3019?3024, 1988","journal-title":"Cancer Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1096\/fasebj.2.11.3294078","volume":"2","author":"L Grossman","year":"1988","unstructured":"Grossman L, Caron PR, Mazur SJ, Oh EY: Repair of DNA-containing pyrimidine dimers. FASEB J 2: 2696?2701, 1988","journal-title":"FASEB J"},{"key":"CR30","first-page":"1737","volume":"45","author":"CA Hoy","year":"1985","unstructured":"Hoy CA, Thompson LH, Mooney CL, Salazar EP: Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res 45: 1737?1743, 1985","journal-title":"Cancer Res"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev.bi.48.070179.004031","volume":"48","author":"PC Hanawalt","year":"1979","unstructured":"Hanawalt PC, Cooper PK, Ganesan AK, Smith CA: DNA repair in bacteria and mammalian cells. Ann Rev Biochem 48: 783?836, 1979","journal-title":"Ann Rev Biochem"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/jnci\/81.13.1020","volume":"81","author":"TT Kwok","year":"1989","unstructured":"Kwok TT, Sutherland RM: Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor. J Natl Cancer Inst 81: 1020?1024, 1989","journal-title":"J Natl Cancer Inst"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1349-7006.1989.tb01695.x","volume":"80","author":"H Amagase","year":"1989","unstructured":"Amagase H, Kakimoto M, Hashimoto K, Fuwa T, Tsukagoshi S: Epidermal growth factor receptor-mediated selective cytotoxicity of antitumor agents towards human xenografts and murine syngeneic solid tumors. Jpn J Cancer Res 80: 670?678, 1989","journal-title":"Jpn J Cancer Res"},{"key":"CR34","first-page":"382","volume":"35","author":"RD Christen","year":"1994","unstructured":"Christen RD, Jones JA, Howell SB: Epidermal growth factor selectively enhances cisplatin toxicity to tumor xenografts in athymic mice. (Abstract). Proc Am Assoc Cancer Res 35: 382, 1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR35","first-page":"21","volume":"44","author":"JD Haley","year":"1990","unstructured":"Haley JD: Regulation of epidermal growth factor receptor expression and activation: a brief review. Proc Soc Exp Biol 44: 21?37, 1990","journal-title":"Proc Soc Exp Biol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1073\/pnas.72.4.1317","volume":"72","author":"S Cohen","year":"1975","unstructured":"Cohen S, Carpenter G: Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA 72: 1317?1321, 1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0092-8674(89)90047-0","volume":"57","author":"B Margolis","year":"1989","unstructured":"Margolis B, Rhee SG, Felder S, Mervic M, Lyall R, Levitzki A, Ullrich A, Zilberstein A, Schlessinger J: EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57: 1101?1107, 1989","journal-title":"Cell"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.2181668","volume":"248","author":"PP Fiore Di","year":"1990","unstructured":"Di Fiore PP, Segatto O, Taylor WG, Aaronson SA, Pierce JH: EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science 248: 79?83, 1990","journal-title":"Science"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.0.1230121","volume":"123","author":"LM Tyson","year":"1989","unstructured":"Tyson LM, Browne CA, Jenkin G, Thorburn GD: The fate and uptake of murine epidermal growth factor in the sheep. J Endocrinol 123: 121?130, 1989","journal-title":"J Endocrinol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/00365528909093078","volume":"24","author":"SJ Konturek","year":"1989","unstructured":"Konturek SJ, Bielansky W, Konturek JW, Oleksy J, Yamazaki J: Release and action of epidermal growth factor on gastric secretion in humans. Scand J Gastroenterol 24: 485?492, 1989","journal-title":"Scand J Gastroenterol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3835(85)90069-2","volume":"28","author":"E Ginsburg","year":"1985","unstructured":"Ginsburg E, Vonderhaar BK: Epidermal growth factor stimulates the growth of A431 tumors in athymic mice. Cancer Lett 28: 143?150, 1985","journal-title":"Cancer Lett"},{"key":"CR42","first-page":"263","volume":"211","author":"Y Murayama","year":"1990","unstructured":"Murayama Y: Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice. Ann Surg 211: 263?268, 1990","journal-title":"Ann Surg"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1349-7006.1990.tb02597.x","volume":"81","author":"H Amagase","year":"1990","unstructured":"Amagase H, Tamura K, Okuhira M, Kakimoto M, Amano H, Hashimoto K, Fuwa T, Tsukagoshi S: Epidermal growth factor prolongs survival time of tumor-bearing mice. Jpn J Cancer Res 81: 495?500, 1990","journal-title":"Jpn J Cancer Res"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0092-8674(87)90707-0","volume":"48","author":"J Graf","year":"1987","unstructured":"Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y: Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48: 989?996, 1987","journal-title":"Cell"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.2961059","volume":"238","author":"Y Iwamoto","year":"1987","unstructured":"Iwamoto Y, Robey FA, Graf J, Sasaki N, Kleinman HK, Yamada Y, Martin GR: YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 238: 1132?1134, 1987","journal-title":"Science"},{"key":"CR46","first-page":"1819","volume":"262","author":"AG Gilman","year":"1987","unstructured":"Gilman AG: G proteins: transducers of receptor-generated signals. Ann Rev Biochem 262: 1819?1825, 1987","journal-title":"Ann Rev Biochem"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev.bi.56.070187.003031","volume":"56","author":"AM Edelman","year":"1987","unstructured":"Edelman AM, Blumenthal DK, Krebs EG: Protein serine\/threonine kinases. Ann Rev Biochem 56: 567?613, 1987","journal-title":"Ann Rev Biochem"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","volume":"78","author":"KB Seamon","year":"1981","unstructured":"Seamon KB, Padgett W, Daly JW: Forskolin: a unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Nat Acad Sci USA 78: 3363?3367, 1981","journal-title":"Proc Nat Acad Sci USA"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ijc.2910480613","volume":"48","author":"SC Mann","year":"1991","unstructured":"Mann SC, Andrews PA, Howell SB: Modulation of cisdiamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48: 866?872, 1991","journal-title":"Int J Cancer"},{"key":"CR50","first-page":"19","volume-title":"Dose-effect Analysis with Microcomputers","author":"J Chou","year":"1986","unstructured":"Chou J, Chou TC: Multiple drug-effect analysis. In: Chou J, Chou TC (eds) Dose-effect Analysis with Microcomputers. Elsevier Science Publishing Company, Inc., Amsterdam, Netherlands, 1986, pp 19?64"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enz Regulation 22: 27?55, 1984","journal-title":"Adv Enz Regulation"},{"key":"CR52","first-page":"149","volume-title":"Ovarian Cancer. Biology, Diagnosis and Management","author":"SB Howell","year":"1992","unstructured":"Howell SB, Christen RD, Andrews PA, Mann SC, Hom DK: Signal transduction pathway regulation of cisplatin sensitivity. In: Sharp F, Mason WP, Creasman W (eds) Ovarian Cancer. Biology, Diagnosis and Management. Chapman & Hall Medical Publishing, London, UK, 1992, pp 149?152"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI116585","volume":"92","author":"RD Christen","year":"1993","unstructured":"Christen RD, Jekunen AP, Jones JA, Thiebaut F, Shalinsky DR, Howell SB:In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J Clin Invest 92: 431?440, 1993","journal-title":"J Clin Invest"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1016\/S0021-9258(18)43377-7","volume":"256","author":"RM Hewick","year":"1981","unstructured":"Hewick RM, Hunkapiller MW, Hood LE, Dreyer WJ: A gas-liquid solid phase peptide and protein sequenator. J Biol Chem 256: 7990?7997, 1981","journal-title":"J Biol Chem"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/S0021-9258(19)67891-9","volume":"266","author":"AM Minotti","year":"1991","unstructured":"Minotti AM, Barlow SB, Cabral F: Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J Biol Chem 266: 3987?3994, 1991","journal-title":"J Biol Chem"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-2952(86)90207-8","volume":"35","author":"V Peyrot","year":"1986","unstructured":"Peyrot V, Briand C, Momburg R, Sari JC:In vitro mechanism study of microtubule assembly inhibition by cis-dichlorodiammine-platinum(II). Biochem Pharmacol 35: 371?375, 1986","journal-title":"Biochem Pharmacol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1096\/fasebj.3.5.2646163","volume":"3","author":"F Cabral","year":"1989","unstructured":"Cabral F, Barlow SB: Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly. FASEB J 3: 1593?1599, 1989","journal-title":"FASEB J"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.3014651","volume":"233","author":"Y Nishizuka","year":"1986","unstructured":"Nishizuka Y: Studies and perspectives of protein kinase C. Science (Washington DC) 233: 305?312, 1986","journal-title":"Science (Washington DC)"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/312315a0","volume":"312","author":"MJ Berridge","year":"1984","unstructured":"Berridge MJ, Irvine RF: Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315?321, 1984","journal-title":"Nature"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0021-9258(19)85886-6","volume":"255","author":"A Kishimoto","year":"1980","unstructured":"Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Proteolytic activation of calcium-activated, phospholipid-dependent protein kinases by calcium-dependent neutral protease. J Biol Chem 255: 2273?2276, 1980","journal-title":"J Biol Chem"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.2910420313","volume":"42","author":"J Hofmann","year":"1988","unstructured":"Hofmann J, Doppler W, Jakob A, Maly K, Posch L, \u00dcberall F, Grunicke HH: Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42: 382?388, 1988","journal-title":"Int J Cancer"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1073\/pnas.85.2.582","volume":"85","author":"RL Fine","year":"1988","unstructured":"Fine RL, Patel J, Chabner BA: Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Nat Acad Sci USA 85: 582?586, 1988","journal-title":"Proc Nat Acad Sci USA"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/S0021-9258(19)38909-4","volume":"265","author":"A Basu","year":"1990","unstructured":"Basu A, Teicher BA, Lazo JS: Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J Biol Chem 265: 8451?8457, 1990","journal-title":"J Biol Chem"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/S0021-9258(19)39638-3","volume":"265","author":"S Isonishi","year":"1990","unstructured":"Isonishi S, Andrews PA, Howell SB: Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J Biol Chem 265: 3623?3627, 1990","journal-title":"J Biol Chem"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/bjc.1994.42","volume":"69","author":"S Isonishi","year":"1994","unstructured":"Isonishi S, Hom DK, Eastman A, Howell SB: Enhancement of sensitivity to platinum(II)-containing drugs by activation of protein kinase C in a human ovarian carcinoma cell line. Br J Cancer 69: 217?221, 1994","journal-title":"Br J Cancer"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/337661a0","volume":"337","author":"DA Brenner","year":"1989","unstructured":"Brenner DA, O'Harra M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumor necrosis factor alpha. Nature (London) 337: 661?663, 1989","journal-title":"Nature (London)"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"19188","DOI":"10.1016\/S0021-9258(18)37408-8","volume":"263","author":"JD Erusalimsky","year":"1988","unstructured":"Erusalimsky JD, Friedberg I, Rozengurt E: Bombesin, diacyglycerol, and phorbol esters rapidly stimulate the phosphorylation of an 80 kD protein kinase C substrate in permeabilized 3T3 cells. J Biol Chem 263: 19188?19194, 1988","journal-title":"J Biol Chem"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116010","volume":"90","author":"S Isonishi","year":"1992","unstructured":"Isonishi S, Jekunen AP, Hom DK, Eastman A, Edelstein PS, Thiebaut FB, Christen RD, Howell SB: Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-?. J Clin Invest 90: 1436?1442, 1992","journal-title":"J Clin Invest"},{"key":"CR69","first-page":"821","volume":"47","author":"MS Naylor","year":"1990","unstructured":"Naylor MS, Malik STA, Stamp GW, Jobling T, Balkwill RF:In situ detection of tumor necrosis factor in human ovarian cancer specimens. Cancer Res 47: 821?825, 1990","journal-title":"Cancer Res"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ijc.2910440529","volume":"44","author":"STA Malik","year":"1989","unstructured":"Malik STA, Griffin DB, Fiers W, Balkwill FR: Paradoxical effects of tumor necrosis factor in experimental ovarian cancer. Int J Cancer 44: 918?925, 1989","journal-title":"Int J Cancer"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0277-5379(90)90044-T","volume":"26","author":"STA Malik","year":"1990","unstructured":"Malik STA, Naylor MS, East N, Oliff A, Balkwill FR: Cells secreting tumor necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 26: 1031?1034, 1990","journal-title":"Eur J Cancer"},{"key":"CR72","first-page":"793","volume":"48","author":"MD Sklar","year":"1988","unstructured":"Sklar MD: Increased resistance to cisplatin in NIH 3T3 cells transformed by ras oncogene. Cancer Res 48: 793?797, 1988","journal-title":"Cancer Res"},{"key":"CR73","first-page":"5903","volume":"51","author":"S Isonishi","year":"1991","unstructured":"Isonishi S, Hom DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo JS, Eastman A, Howell SB: Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. Cancer Res 51: 5903?5909, 1991","journal-title":"Cancer Res"},{"key":"CR74","first-page":"825","volume":"3","author":"NJ Holbrook","year":"1991","unstructured":"Holbrook NJ, Fornace AJ: Response to adversity: molecular control of gene activation following genotoxic stress. New Biol 3: 825?833, 1991","journal-title":"New Biol"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0092-8674(05)80058-3","volume":"71","author":"Y Devary","year":"1992","unstructured":"Devary Y, Gottlieb RA, Smeal T, Karin M: The mammalian ultraviolet response is triggered by activation of src tyrosine kinases. Cell 71: 1081?1091, 1992","journal-title":"Cell"},{"key":"CR76","first-page":"503","volume":"34","author":"DP Gately","year":"1993","unstructured":"Gately DP, Jones JA, Howell SB: Induction of gadd153in vitro andin vivo by cisplatin. (Abstract). Proc Am Assoc Cancer Res 34: 503, 1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR77","first-page":"433","volume":"34","author":"G Los","year":"1993","unstructured":"Los G, Barton RM, Nakata B, Lee LK, van Veelen LR, Howell SB: DNA damage early-response genes as a tool to monitor tumor injury following chemotherapy. (Abstract). Proc Am Assoc Cancer Res 34: 433, 1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR78","first-page":"111","volume":"12","author":"JA Jones","year":"1993","unstructured":"Jones JA, Gately DP, Albright KD, Christen RD, McClay EF, Howell SB: Induction of gadd153 in human ovarian and human melanoma xenografts as an indicator of genotoxic injury. (Abstract). Proc Am Soc Clin Oncol 12: 111, 1993","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR79","first-page":"599","volume":"35","author":"DP Gately","year":"1994","unstructured":"Gately DP, Howell SB: Induction of gadd153 promoter activity by cisplatin and taxol proceeds through separate pathways. (Abstract). Proc Am Assoc Cancer Res 35: 599, 1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1073\/pnas.87.16.6258","volume":"87","author":"RS Friling","year":"1991","unstructured":"Friling RS, BenSimon A, Tichauer Y, Daniel V: Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 87: 6258?6262, 1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/MCB.11.2.979","volume":"11","author":"R Kumar","year":"1991","unstructured":"Kumar R, Shepard HM, Mendelsohn J: Regulation of phosphorylation of the c-erbB2\/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol Cell Biol 11: 979?986, 1991","journal-title":"Mol Cell Biol"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.1683495","volume":"254","author":"I Pastan","year":"1991","unstructured":"Pastan I, Fitzgerald D: Recombinant toxins for cancer treatment. Science 254: 1173?1177, 1991","journal-title":"Science"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689635\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:46:17Z","timestamp":1625010377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00689635"],"URL":"https:\/\/doi.org\/10.1007\/bf00689635","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}